Cresset Asset Management’s Fresenius Medical Care FMS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-8,846
Closed -$211K 1703
2025
Q4
$211K Sell
8,846
-6
-0.1% -$149 ﹤0.01% 1469
2025
Q3
$233K Buy
8,852
+1
+0% +$26 ﹤0.01% 1357
2025
Q2
$253K Sell
8,851
-6,582
-43% -$177K ﹤0.01% 1209
2025
Q1
$384K Sell
15,433
-4,967
-24% -$118K ﹤0.01% 1200
2024
Q4
$462K Sell
20,400
-34,198
-63% -$742K ﹤0.01% 1124
2024
Q3
$1.16M Buy
54,598
+18,541
+51% +$365K ﹤0.01% 1082
2024
Q2
$688K Buy
36,057
+22,121
+159% +$451K ﹤0.01% 1280
2024
Q1
$269K Buy
+13,936
New +$276K ﹤0.01% 1638
2019
Q2
Sell
-1,399
Closed -$57K 893
2019
Q1
$57K Sell
1,399
-1,142
-45% -$42.6K ﹤0.01% 737
2018
Q4
$82K Buy
+2,541
New +$103K ﹤0.01% 370

Other funds holding FMS

Cresset Asset Management's FMS Position: Q1 2026 in Review

Cresset Asset Management sold out of Fresenius Medical Care (FMS) in Q1 2026, closing a stake of 8,846 shares — an estimated $211K sold.

Cresset Asset Management first reported a position in FMS in Q4 2018 and held it in 10 quarters. The position peaked at $1.16M in Q3 2024. 220 funds tracked by Wall St. Rank hold FMS as of Q1 2026.

  • Cresset Asset Management reported no remaining Fresenius Medical Care position as of Q1 2026 after selling out during the quarter.
  • Cresset Asset Management sold 8,846 Fresenius Medical Care shares in Q1 2026, an estimated $211K.
  • Cresset Asset Management first reported a position in Fresenius Medical Care in Q4 2018 and held it in 10 quarters.
  • Cresset Asset Management's Fresenius Medical Care position peaked at $1.16M in Q3 2024.
  • 220 funds tracked by Wall St. Rank held Fresenius Medical Care as of Q1 2026.

Based on Cresset Asset Management's 13F filing for Q1 2026, filed 15 May 2026.